Robust Earnings Momentum Evident as Over Half of Stocks Report Positive Q3 Results

1 hour ago
share
Share Via
The December 2025 quarter earnings season has delivered encouraging signs of recovery and growth, with 409 companies declaring results and a notable improvement in positive earnings surprises across market capitalisation segments. Mid and small caps have outperformed large caps in terms of profitability, signalling a broad-based uptrend in corporate earnings.
Robust Earnings Momentum Evident as Over Half of Stocks Report Positive Q3 Results



Quarterly Earnings Overview and Trends


The latest earnings season saw 54.0% of companies reporting positive results for the December 2025 quarter, a marked improvement compared to 43.0% in September 2025 and 40.0% in June 2025. This upward trajectory suggests strengthening corporate fundamentals and better-than-expected operational performance across sectors. The March 2025 quarter had a 44.0% positive result rate, underscoring the recent acceleration in earnings momentum.


Such a rise in positive earnings outcomes is significant given the macroeconomic challenges faced globally, including inflationary pressures and geopolitical uncertainties. The data indicates that companies have been able to navigate these headwinds effectively, with many reporting robust revenue growth and margin expansion.



Market Capitalisation Analysis: Mid and Small Caps Lead


Breaking down the results by market capitalisation reveals a distinct pattern. Large-cap companies reported a positive result rate of 37.0%, considerably lower than their mid-cap and small-cap counterparts, which posted 61.0% and 56.0% respectively. This divergence highlights the resilience and growth potential of mid and small caps, which often benefit from niche market positioning and agility in adapting to changing market conditions.


Large caps, while generally more stable, appear to be facing more pronounced margin pressures or cyclical challenges in certain sectors. Investors may find greater alpha opportunities in mid and small caps given their superior earnings beat ratios this quarter.



Sectoral Highlights and Top Performers


Among the large-cap stocks, Piramal Finance stood out with strong earnings, although sector-specific details remain undisclosed. In the mid-cap space, Laurus Labs from the Pharmaceuticals & Biotechnology sector delivered an outstanding performance, showcasing significant growth across key financial metrics.


Small-cap stocks also impressed, with Indo Thai Securities from the Capital Markets sector emerging as a top performer. Micro-cap companies such as String Metaverse (Paper, Forest & Jute Products) and Sera Investments (Non-Banking Financial Company) also reported exceptional results, underscoring the breadth of earnings strength across market segments.




Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.



  • - Recent Top 1% qualifier

  • - Impressive market performance

  • - Sector leader


See What's Driving the Rally →




Laurus Labs: A Mid-Cap Beacon of Growth


Laurus Labs Ltd., with a market capitalisation of ₹54,911.51 crores, has demonstrated exceptional financial performance in the December 2025 quarter. The company’s profit before tax excluding other income (PBT less OI) surged by 164.56% to ₹320.80 crores, while profit after tax (PAT) soared 172.7% to ₹251.66 crores. This remarkable growth was accompanied by a 25.67% increase in net sales, reaching ₹1,778.29 crores, the highest recorded for the company.


Operating profit to interest ratio reached an impressive 12.38 times, reflecting strong operational efficiency and manageable debt levels. Laurus Labs also posted its highest quarterly earnings per share (EPS) at ₹4.66 and maintained a low debt-to-equity ratio of 0.46 times as of the half-year, underscoring its prudent capital structure.


The company’s PBDIT (profit before depreciation, interest and tax) stood at ₹480.21 crores, with operating profit to net sales ratio peaking at 27.00%, signalling robust margin expansion. These metrics collectively indicate Laurus Labs’ strong competitive positioning within the Pharmaceuticals & Biotechnology sector and its ability to capitalise on favourable market dynamics.



Sectoral Earnings Patterns and Outlook


The Pharmaceuticals & Biotechnology sector, exemplified by Laurus Labs, continues to be a key driver of earnings growth, benefiting from increased demand for healthcare products and innovation in drug development. Capital Markets firms like Indo Thai Securities have also shown resilience, supported by rising market activity and financial product diversification.


Conversely, some large-cap sectors appear to be grappling with margin pressures and slower growth, which may temper near-term optimism. However, the overall earnings landscape remains constructive, with improving profitability trends and a higher proportion of companies beating estimates.



Upcoming Earnings to Watch


Investors should keep an eye on the forthcoming results from Avantel Ltd scheduled for 25 January 2026, Axis Bank Ltd on 26 January 2026, and CG Power & Industrial Solutions Ltd on 27 January 2026. These companies operate in sectors that could provide further insights into the evolving earnings environment and market sentiment.



Aggregate Profit Growth and Market Implications


The aggregate profit growth reflected in the December quarter results signals a positive inflection point for corporate India. The rising trend in positive earnings surprises, particularly among mid and small caps, suggests that earnings upgrades may continue in the near term, potentially supporting broader market rallies.


However, investors should remain cautious of valuation levels and sector-specific risks, especially in large caps where earnings growth appears more muted. Diversification across market capitalisation and sectors with strong earnings momentum could be a prudent strategy in the current environment.



Conclusion


The December 2025 quarterly earnings season has reinforced the narrative of a gradual but steady recovery in corporate profitability. With over half of the companies reporting positive results and mid and small caps leading the charge, the market is witnessing a broad-based improvement in fundamentals. Strong performances from companies like Laurus Labs and Indo Thai Securities highlight the opportunities available for discerning investors willing to look beyond the headline large caps.


As the earnings season progresses with key results due in the coming days, market participants will be closely analysing these trends to gauge the sustainability of earnings growth and its impact on market valuations.






Mojo Stocks - The Top 1% Picks across Markets

Top 10 Large Cap Mid Cap Small Cap
{{col.header}}
Latest
OPEN CALL
CLOSED CALL
{{s[col.key]}} {{s.change_value}}
{{ s.score.value }} - {{ s.score.call_type }}
{{ s.dot_summary.score }} - {{ s.dot_summary.scoreText }}
{{s[col.key]}} {{col.extra}}

Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News